Kenza Mamouni

Kenza Mamouni

UNVERIFIED PROFILE

Are you Kenza Mamouni?   Register this Author

Register author
Kenza Mamouni

Kenza Mamouni

Publications by authors named "Kenza Mamouni"

Are you Kenza Mamouni?   Register this Author

10Publications

217Reads

46Profile Views

Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.

Cancer Lett 2019 04 18;446:62-72. Epub 2019 Jan 18.

Molecular Oncology and Biomarkers Program, Georgia Cancer Center, Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, USA; Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA; MetCure Therapeutics LLC, Atlanta, GA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2019.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361683PMC
April 2019

Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.

Mol Cancer Ther 2018 09 15;17(9):1859-1870. Epub 2018 Jun 15.

Molecular Oncology and Biomarkers Program, Georgia Cancer Center, Augusta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-1176DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125160PMC
September 2018

PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin.

Cell Death Dis 2018 09 12;9(9):931. Epub 2018 Sep 12.

Cancer Research Center of Toulouse (CRCT), INSERM, Université de Toulouse, Université Toulouse III Paul Sabatier, CNRS, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-018-0981-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135836PMC
September 2018

A Novel Flavonoid Composition Targets Androgen Receptor Signaling and Inhibits Prostate Cancer Growth in Preclinical Models.

Neoplasia 2018 08 4;20(8):789-799. Epub 2018 Jul 4.

Molecular Oncology and Biomarkers Program, Georgia Cancer Center; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, USA; Department of Urology and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA; MetCure Therapeutics LLC, Atlanta, GA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2018.06.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034581PMC
August 2018

Mifepristone Has Limited Activity to Enhance the Efficacy of Docetaxel and Enzalutamide Against Bone Metastatic and Castration-Resistant Prostate Cancer.

Anticancer Res 2017 11;37(11):6235-6243

Georgia Cancer Center and Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, U.S.A.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/37/11/6235.abstract
Publisher Site
http://dx.doi.org/10.21873/anticanres.12074DOI Listing
November 2017

Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.

Nanoscale 2016 Jul 10;8(25):12668-82. Epub 2016 Mar 10.

Departments of Chemistry, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30303, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5nr09071gDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528195PMC
July 2016

RhoB promotes γH2AX dephosphorylation and DNA double-strand break repair.

Mol Cell Biol 2014 Aug 9;34(16):3144-55. Epub 2014 Jun 9.

Cancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.01525-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135599PMC
August 2014

RhoB promotes cancer initiation by protecting keratinocytes from UVB-induced apoptosis but limits tumor aggressiveness.

J Invest Dermatol 2014 Jan 21;134(1):203-212. Epub 2013 Jun 21.

Inserm, UMR 1037-CRCT, Toulouse, France; Université Paul Sabatier, Toulouse, France; Department of Biopathology, Institut Claudius Regaud, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2013.278DOI Listing
January 2014